{"gene":"GLB1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1968,"finding":"Profound deficiency of β-galactosidase activity (failing to cleave both p-nitrophenyl-β-D-galactopyranoside and GM1 ganglioside labeled with C14) was identified in tissues of patients with generalized gangliosidosis, establishing that defective lysosomal β-galactosidase (GLB1) is the fundamental enzymatic defect responsible for GM1 ganglioside accumulation in this disease.","method":"Enzymatic activity assay on liver, spleen, kidney and brain tissue homogenates from patients","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 — direct in vitro enzymatic assay with defined substrate, foundational paper replicated extensively","pmids":["5647842"],"is_preprint":false},{"year":1985,"finding":"Lysosomal β-galactosidase exists as a high-density multimeric complex that associates with both a 32-kDa protective protein (CTSA/cathepsin A) and neuraminidase, and formation of this multiprotein complex is required for neuraminidase catalytic activity; absence of the protective protein in galactosialidosis explains the secondary neuraminidase deficiency in that disorder.","method":"β-galactosidase affinity chromatography, immunotitration with monospecific antibodies, sucrose density gradient centrifugation of human placental fractions","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1–2 — biochemical reconstitution and affinity chromatography with multiple orthogonal methods; foundational for understanding the lysosomal multienzyme complex","pmids":["3922758"],"is_preprint":false},{"year":1993,"finding":"An alternatively spliced, enzymatically inactive 67-kDa form of β-galactosidase (encoded by GLB1) was identified as immunologically and functionally similar to the 67-kDa cell-surface elastin/laminin-binding protein (EBP); a unique peptide (S-GAL) derived from the frameshift-generated sequence of this splice variant binds elastin and laminin but not fibronectin or collagens.","method":"Antibody raised to unique splice-variant peptide; Western blot; elastin and laminin affinity column binding assays; immunohistochemistry of aortic tissue","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (affinity binding, immunology, peptide competition) in a single study; replicated in subsequent work","pmids":["8383699"],"is_preprint":false},{"year":1998,"finding":"The 67-kDa alternatively spliced variant of GLB1 (S-gal) was conclusively identified as the elastin/laminin-binding protein: full-length S-gal cDNA expressed in COS-1 cells and EBP-deficient smooth muscle cells produced a 67-kDa protein that localized to the cell surface, bound elastin, increased cell adhesion to elastin, and corrected impaired elastic fiber assembly in deficient cells.","method":"cDNA transfection, in vitro transcription/translation, elastin/laminin affinity chromatography, immunolocalization, cell adhesion assay, elastic fiber assembly assay in EBP-deficient smooth muscle cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in multiple cell types with functional rescue; definitive identification of splice variant function","pmids":["9497360"],"is_preprint":false},{"year":2005,"finding":"The alternatively spliced 67-kDa EBP (GLB1 splice variant) forms a cell surface-targeted multiprotein complex with protective protein/cathepsin A and sialidase (neuraminidase-1); this complex facilitates elastic fiber assembly by enabling neuraminidase-1 to remove terminal sialic acids from microfibrillar glycoproteins, exposing galactosugars that interact with the galectin domain of EBP and trigger tropoelastin release and assembly.","method":"Co-immunoprecipitation, sialidase inhibitor treatment, neuraminidase-1 cDNA transduction of sialidosis/galactosialidosis patient fibroblasts, chick embryo elastogenesis assay, bacterial sialidase rescue experiment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including genetic rescue in patient-derived cells and functional reconstitution","pmids":["16314420"],"is_preprint":false},{"year":2006,"finding":"Senescence-associated β-galactosidase (SA-β-gal) activity detectable at pH 6.0 in senescent cells originates from GLB1, the gene encoding lysosomal β-D-galactosidase: fibroblasts from GM1-gangliosidosis patients (defective lysosomal β-galactosidase) and normal late-passage fibroblasts depleted of GLB1 mRNA by shRNA both failed to express SA-β-gal despite undergoing replicative senescence; SA-β-gal induction during senescence was due at least in part to increased GLB1 protein expression.","method":"shRNA knockdown of GLB1, SA-β-gal activity assay at pH 6.0, patient fibroblasts from GM1-gangliosidosis, HPV E7 repression-induced senescence model, Western blot","journal":"Aging cell","confidence":"High","confidence_rationale":"Tier 1–2 — loss-of-function (shRNA and genetic disease cells) with specific phenotypic readout across multiple model systems; widely replicated","pmids":["16626397"],"is_preprint":false},{"year":2010,"finding":"Genotype-phenotype analysis of 28 GLB1 mutations in GM1 gangliosidosis patients revealed that overexpression of missense mutations in COS-1 cells and assessment of subcellular localization of mutant proteins in fibroblasts can predict phenotype specificity; mutations producing truncated proteins consistently result in typical CDPX2-like severe phenotype, while missense mutations show variable phenotypic outcomes, indicating that residual β-galactosidase enzyme activity correlates with clinical severity.","method":"Overexpression in COS-1 cells, immunofluorescence subcellular localization in patient fibroblasts, DNA sequencing, β-galactosidase enzyme activity assay","journal":"Clinical genetics","confidence":"Medium","confidence_rationale":"Tier 2–3 — cell-based expression with functional readout; single study but covers multiple alleles with defined phenotypic correlation","pmids":["20175788"],"is_preprint":false},{"year":2011,"finding":"An alternatively spliced form of GLB1 (the EBP splice variant) is present on human choroidal endothelial cells and acts as a cell-surface receptor for elastin-derived peptides (EDPs), mediating their pro-angiogenic effects; EDP-induced cell migration was blocked by inhibitors targeting EBP/GLB1 but not other EDP-binding proteins, and elevated circulating EDPs in vivo increased collagen IV expression and deposition in the RPE/choroid.","method":"RT-PCR for GLB1 isoform expression, cell migration assay with receptor-specific inhibitors, in vivo mouse EDP injection with electroretinography, transmission electron microscopy, and microarray analysis","journal":"Matrix biology","confidence":"Medium","confidence_rationale":"Tier 2–3 — receptor identification by pharmacological inhibition and expression analysis, supported by in vivo functional data","pmids":["22178079"],"is_preprint":false},{"year":2015,"finding":"GLB1 protein (lysosomal β-galactosidase) accumulates in replicative senescence and therapy-induced senescence in prostate epithelial cells and cancer lines, correlating with senescent morphology and p16/CDKN2A expression; in tissue microarrays, GLB1 expression is elevated in high-grade prostatic intraepithelial neoplasia and primary cancer compared with benign tissue, with senescent cells showing low Ki67 and elevated HP1γ.","method":"Immunofluorescent staining with new GLB1 antibody, automated quantitative imaging (AQUA and Vectra), replicative senescence passage assay in primary cultures, chemotherapy-induced senescence in PCa lines","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 — direct protein localization and expression correlation with senescence markers; functional link to senescence biology established but mechanistic depth limited","pmids":["25876105"],"is_preprint":false},{"year":2019,"finding":"CRISPR/Cas9 knockout of GLB1 in human iPSC-derived cerebral organoids caused progressive accumulation of GM1 ganglioside; microinjection of AAV9-GLB1 vector into these organoids significantly increased β-galactosidase activity and reduced GM1 ganglioside content, demonstrating that GLB1 gene delivery is sufficient to restore enzymatic function and reduce substrate storage in a human CNS model.","method":"CRISPR/Cas9 genome editing targeting GLB1 exons 2 and 6, cerebral organoid generation, β-galactosidase enzyme activity assay, GM1 ganglioside quantification, AAV9-GLB1 microinjection","journal":"Molecular genetics and metabolism reports","confidence":"High","confidence_rationale":"Tier 1–2 — genetic knockout with substrate accumulation phenotype and genetic rescue by AAV9-GLB1 in a human CNS organoid model; proof-of-concept with rigorous controls","pmids":["31534909"],"is_preprint":false},{"year":2022,"finding":"A Glb1-2A-mCherry (GAC) knock-in reporter allele at the endogenous Glb1 locus in mice showed that GLB1/lysosomal β-galactosidase protein levels increase linearly with chronological age in middle-aged mice and are exponentially elevated in bleomycin-induced pathological senescence in the lung; treatment with senolytics dasatinib and quercetin reduced GAC signal in bleomycin-treated mice, confirming that GLB1 expression marks senescent cell burden in vivo.","method":"CRISPR knock-in reporter allele (Glb1-2A-mCherry), cohort aging study, bleomycin lung injury model, in vivo imaging, senolytic drug treatment","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 — endogenous reporter knock-in with genetic and pharmacological validation across multiple experimental conditions","pmids":["36396643"],"is_preprint":false}],"current_model":"GLB1 encodes lysosomal β-D-galactosidase, whose deficiency causes GM1 gangliosidosis through accumulation of GM1 ganglioside; an alternatively spliced, enzymatically inactive 67-kDa isoform functions as the cell-surface elastin/laminin-binding protein (EBP) that, in a multiprotein complex with cathepsin A/protective protein and neuraminidase-1, acts as a recyclable chaperone facilitating tropoelastin secretion and elastic fiber assembly; the canonical lysosomal form is upregulated during cellular senescence and is the molecular origin of senescence-associated β-galactosidase (SA-β-gal) activity."},"narrative":{"teleology":[{"year":1968,"claim":"Establishing the primary enzymatic defect: demonstrating that profound loss of β-galactosidase activity is the biochemical basis of generalized (GM1) gangliosidosis resolved the question of which enzyme is responsible for GM1 ganglioside catabolism.","evidence":"Enzymatic activity assay on patient tissue homogenates using synthetic and radiolabeled GM1 substrates","pmids":["5647842"],"confidence":"High","gaps":["No molecular cloning or gene identification at this stage","Genotype–phenotype spectrum not yet explored"]},{"year":1985,"claim":"Identifying the lysosomal multienzyme complex: showing that β-galactosidase, protective protein/cathepsin A, and neuraminidase form a high-molecular-weight complex — and that the protective protein is essential for neuraminidase activity — explained the secondary neuraminidase deficiency in galactosialidosis and established GLB1 as a structural component of this complex.","evidence":"Affinity chromatography, immunotitration, and sucrose gradient centrifugation of human placental lysosomes","pmids":["3922758"],"confidence":"High","gaps":["Stoichiometry and atomic structure of the complex unresolved","Mechanism by which protective protein activates neuraminidase not defined"]},{"year":1993,"claim":"Discovering the EBP splice variant: identifying an alternatively spliced, enzymatically inactive 67-kDa GLB1 product as the elastin/laminin-binding protein revealed a bifunctional gene with roles in both lysosomal catabolism and extracellular matrix biology.","evidence":"Antibody against the unique splice-variant peptide (S-GAL), Western blot, elastin/laminin affinity chromatography","pmids":["8383699"],"confidence":"High","gaps":["Whether EBP functions independently or requires cofactors for elastic fiber assembly was unknown","In vivo relevance of EBP not yet tested"]},{"year":1998,"claim":"Functional reconstitution of EBP: expressing full-length S-gal cDNA in EBP-deficient smooth muscle cells restored cell-surface elastin binding, adhesion, and elastic fiber assembly, definitively proving the splice variant is the functional EBP.","evidence":"cDNA transfection into COS-1 and EBP-deficient vascular smooth muscle cells with functional rescue assays","pmids":["9497360"],"confidence":"High","gaps":["Molecular mechanism triggering tropoelastin release from EBP not resolved","Role of associated proteins in elastic fiber assembly not defined"]},{"year":2005,"claim":"Elucidating the EBP-mediated elastic fiber assembly mechanism: showing that the EBP/CTSA/NEU1 cell-surface complex uses neuraminidase-1 to desialylate microfibrillar glycoproteins, exposing galactosugars that trigger tropoelastin release, provided a unified mechanism linking the lysosomal multienzyme complex components to extracellular elastogenesis.","evidence":"Co-immunoprecipitation, sialidase inhibitors, neuraminidase-1 reconstitution in patient fibroblasts, chick embryo elastogenesis assays","pmids":["16314420"],"confidence":"High","gaps":["Structural basis of EBP galectin-domain recognition of galactosugars unresolved","Recycling dynamics of EBP at the cell surface not quantified"]},{"year":2006,"claim":"Identifying the molecular origin of SA-β-gal: demonstrating that senescence-associated β-galactosidase activity derives from GLB1 — via GLB1 shRNA knockdown and GM1-gangliosidosis patient cells — resolved the long-standing question of the enzyme's identity and showed that GLB1 protein is upregulated during senescence.","evidence":"shRNA knockdown of GLB1, SA-β-gal assay at pH 6.0, GM1-gangliosidosis patient fibroblasts, Western blot","pmids":["16626397"],"confidence":"High","gaps":["Mechanism driving GLB1 transcriptional or translational upregulation in senescence not identified","Functional significance of elevated β-galactosidase in senescent cells (beyond biomarker) unknown"]},{"year":2010,"claim":"Mapping genotype–phenotype correlations: systematic analysis of 28 GLB1 mutations showed that residual enzyme activity and subcellular localization of mutant proteins predict clinical severity, advancing understanding of how specific mutations translate to disease spectrum in GM1 gangliosidosis.","evidence":"Overexpression of mutant alleles in COS-1 cells, immunofluorescence localization in patient fibroblasts, enzyme activity assays","pmids":["20175788"],"confidence":"Medium","gaps":["No in vivo validation of genotype–phenotype predictions","Structural basis for misfolding of specific mutants not determined"]},{"year":2019,"claim":"Proving gene therapy feasibility in a human CNS model: CRISPR knockout of GLB1 in iPSC-derived cerebral organoids recapitulated GM1 ganglioside accumulation, and AAV9-GLB1 delivery rescued enzymatic activity and reduced storage, providing preclinical evidence for gene replacement therapy.","evidence":"CRISPR/Cas9 knockout in cerebral organoids, AAV9-GLB1 microinjection, enzyme and ganglioside quantification","pmids":["31534909"],"confidence":"High","gaps":["Long-term durability of gene therapy correction not assessed","Cross-correction efficiency in complex brain tissue architecture not evaluated"]},{"year":2022,"claim":"Validating GLB1 as an in vivo senescence biomarker: an endogenous Glb1-2A-mCherry knock-in reporter demonstrated that GLB1 expression increases linearly with age and exponentially in pathological senescence, and that senolytic treatment reduces this signal, establishing GLB1 as a quantitative marker of senescent cell burden in living animals.","evidence":"CRISPR knock-in reporter mouse, aging cohort, bleomycin lung injury model, dasatinib+quercetin senolytic treatment, in vivo imaging","pmids":["36396643"],"confidence":"High","gaps":["Whether GLB1 upregulation is a causal contributor to senescence phenotypes or purely a consequence remains unanswered","Mechanism of transcriptional/translational control of GLB1 during aging still unresolved"]},{"year":null,"claim":"The transcriptional and translational regulatory mechanisms that drive GLB1 upregulation during senescence and aging remain undefined, and whether elevated β-galactosidase activity plays a functional role in the senescent phenotype (beyond serving as a biomarker) is an open question.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural model of the full lysosomal multienzyme complex","Whether EBP splice-variant dysregulation contributes to age-related vascular pathology not tested","Functional consequence of elevated lysosomal β-galactosidase in senescent cells unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,1,9]},{"term_id":"GO:0098631","term_label":"cell adhesion mediator activity","supporting_discovery_ids":[2,3,7]}],"localization":[{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[0,1,5,9]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,3,4,7]}],"pathway":[{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,9]},{"term_id":"R-HSA-1474244","term_label":"Extracellular matrix organization","supporting_discovery_ids":[3,4]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,6,9]}],"complexes":["Lysosomal multienzyme complex (GLB1–CTSA–NEU1)","EBP cell-surface complex (67-kDa GLB1 splice variant–CTSA–NEU1)"],"partners":["CTSA","NEU1"],"other_free_text":[]},"mechanistic_narrative":"GLB1 encodes lysosomal β-D-galactosidase, an acid hydrolase that cleaves terminal β-galactosyl residues from glycosphingolipids, glycoproteins, and keratan sulfate, and whose deficiency causes the lysosomal storage disorder GM1 gangliosidosis through accumulation of GM1 ganglioside [PMID:5647842, PMID:31534909]. Within the lysosome, GLB1 functions as part of a multienzyme complex with protective protein/cathepsin A (CTSA) and neuraminidase-1 (NEU1), and this association is required for neuraminidase catalytic activity [PMID:3922758, PMID:16314420]. An alternatively spliced, enzymatically inactive 67-kDa isoform serves as the elastin/laminin-binding protein (EBP) on the cell surface, where it chaperones tropoelastin secretion and elastic fiber assembly by coordinating with CTSA and NEU1 to release tropoelastin upon exposure of galactosugars on microfibrils [PMID:8383699, PMID:9497360, PMID:16314420]. The canonical lysosomal enzyme is also the molecular source of senescence-associated β-galactosidase (SA-β-gal) activity: GLB1 protein is upregulated during replicative and therapy-induced senescence, and its expression increases with chronological age in vivo [PMID:16626397, PMID:36396643]."},"prefetch_data":{"uniprot":{"accession":"P16278","full_name":"Beta-galactosidase","aliases":["Acid beta-galactosidase","Lactase","Elastin receptor 1"],"length_aa":677,"mass_kda":76.1,"function":"Cleaves beta-linked terminal galactosyl residues from gangliosides, glycoproteins, and glycosaminoglycans Has no beta-galactosidase catalytic activity, but plays functional roles in the formation of extracellular elastic fibers (elastogenesis) and in the development of connective tissue. Seems to be identical to the elastin-binding protein (EBP), a major component of the non-integrin cell surface receptor expressed on fibroblasts, smooth muscle cells, chondroblasts, leukocytes, and certain cancer cell types. In elastin producing cells, associates with tropoelastin intracellularly and functions as a recycling molecular chaperone which facilitates the secretions of tropoelastin and its assembly into elastic fibers","subcellular_location":"Cytoplasm, perinuclear region","url":"https://www.uniprot.org/uniprotkb/P16278/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GLB1","classification":"Not Classified","n_dependent_lines":8,"n_total_lines":1208,"dependency_fraction":0.006622516556291391},"opencell":{"profiled":true,"resolved_as":"EBP","ensg_id":"ENSG00000147155","cell_line_id":"CID000289","localizations":[{"compartment":"vesicles","grade":3},{"compartment":"er","grade":2}],"interactors":[{"gene":"CANX","stoichiometry":0.2},{"gene":"LPCAT1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000289","total_profiled":1310},"omim":[{"mim_id":"613111","title":"CATHEPSIN A; CTSA","url":"https://www.omim.org/entry/613111"},{"mim_id":"612770","title":"PHOSPHATIDYLSERINE DECARBOXYLASE; PISD","url":"https://www.omim.org/entry/612770"},{"mim_id":"611458","title":"GALACTOSIDASE, BETA-1; GLB1","url":"https://www.omim.org/entry/611458"},{"mim_id":"608272","title":"NEURAMINIDASE 1; NEU1","url":"https://www.omim.org/entry/608272"},{"mim_id":"253010","title":"MUCOPOLYSACCHARIDOSIS, TYPE IVB; MPS4B","url":"https://www.omim.org/entry/253010"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"},{"location":"Golgi apparatus","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/GLB1"},"hgnc":{"alias_symbol":["EBP"],"prev_symbol":["ELNR1"]},"alphafold":{"accession":"P16278","domains":[{"cath_id":"3.20.20.80","chopping":"35-357","consensus_level":"high","plddt":97.9173,"start":35,"end":357},{"cath_id":"2.60.120.260","chopping":"376-381_547-640","consensus_level":"high","plddt":94.1607,"start":376,"end":640},{"cath_id":"2.60.120.260","chopping":"396-515","consensus_level":"high","plddt":97.3488,"start":396,"end":515}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P16278","model_url":"https://alphafold.ebi.ac.uk/files/AF-P16278-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P16278-F1-predicted_aligned_error_v6.png","plddt_mean":90.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GLB1","jax_strain_url":"https://www.jax.org/strain/search?query=GLB1"},"sequence":{"accession":"P16278","fasta_url":"https://rest.uniprot.org/uniprotkb/P16278.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P16278/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P16278"}},"corpus_meta":[{"pmid":"1840554","id":"PMC_1840554","title":"Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.","date":"1991","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/1840554","citation_count":1511,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2850264","id":"PMC_2850264","title":"Isolation of a recombinant copy of the gene encoding C/EBP.","date":"1988","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/2850264","citation_count":926,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18981473","id":"PMC_18981473","title":"PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale.","date":"2008","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/18981473","citation_count":688,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2494700","id":"PMC_2494700","title":"The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite.","date":"1989","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2494700","citation_count":611,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8754828","id":"PMC_8754828","title":"Signals from the stressed endoplasmic reticulum induce C/EBP-homologous protein (CHOP/GADD153).","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8754828","citation_count":592,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7651415","id":"PMC_7651415","title":"Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7651415","citation_count":563,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7557387","id":"PMC_7557387","title":"Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis.","date":"1995","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/7557387","citation_count":456,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1371993","id":"PMC_1371993","title":"Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1371993","citation_count":280,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9418879","id":"PMC_9418879","title":"The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation.","date":"1998","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9418879","citation_count":238,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15944395","id":"PMC_15944395","title":"Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors.","date":"2005","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/15944395","citation_count":237,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8530141","id":"PMC_8530141","title":"The C/EBP family of transcription factors.","date":"1995","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/8530141","citation_count":220,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8756629","id":"PMC_8756629","title":"C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter.","date":"1996","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8756629","citation_count":208,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23160954","id":"PMC_23160954","title":"C/EBP transcription factors mediate epicardial activation during heart development and injury.","date":"2012","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/23160954","citation_count":188,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23665916","id":"PMC_23665916","title":"C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements.","date":"2013","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/23665916","citation_count":188,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9199295","id":"PMC_9199295","title":"CREB controls LAP/C/EBP beta transcription.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9199295","citation_count":175,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12441050","id":"PMC_12441050","title":"An essential role for a MEK-C/EBP pathway during growth factor-regulated cortical neurogenesis.","date":"2002","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/12441050","citation_count":170,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29230213","id":"PMC_29230213","title":"Transcription Factor C/EBP Homologous Protein in Health and Diseases.","date":"2017","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/29230213","citation_count":164,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7929820","id":"PMC_7929820","title":"C/EBP beta regulation of the tumor necrosis factor alpha gene.","date":"1994","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/7929820","citation_count":161,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20974859","id":"PMC_20974859","title":"Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20974859","citation_count":158,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14688407","id":"PMC_14688407","title":"Dominant-negative C/EBP disrupts mitotic clonal expansion and differentiation of 3T3-L1 preadipocytes.","date":"2003","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/14688407","citation_count":157,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11353682","id":"PMC_11353682","title":"Altered expression of C/EBP family members results in decreased adipogenesis with aging.","date":"2001","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11353682","citation_count":145,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11792321","id":"PMC_11792321","title":"Mechanism of c-Myb-C/EBP beta cooperation from separated sites on a promoter.","date":"2002","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11792321","citation_count":133,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9032264","id":"PMC_9032264","title":"Cloning of the novel human myeloid-cell-specific C/EBP-epsilon transcription factor.","date":"1997","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9032264","citation_count":124,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22653339","id":"PMC_22653339","title":"C/EBP homologous protein contributes to cytokine-induced pro-inflammatory responses and apoptosis in β-cells.","date":"2012","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/22653339","citation_count":123,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1892816","id":"PMC_1892816","title":"DNA-induced increase in the alpha-helical content of C/EBP and GCN4.","date":"1991","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1892816","citation_count":114,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11239167","id":"PMC_11239167","title":"The role of C/EBP(epsilon) in the terminal stages of granulocyte differentiation.","date":"2001","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/11239167","citation_count":110,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7501458","id":"PMC_7501458","title":"Ig/EBP (C/EBP gamma) is a transdominant negative inhibitor of C/EBP family transcriptional activators.","date":"1995","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/7501458","citation_count":108,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10319019","id":"PMC_10319019","title":"The C/EBP family of transcription factors in the liver and other organs.","date":"1998","source":"International journal of experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/10319019","citation_count":104,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32673519","id":"PMC_32673519","title":"JAM-A Acts via C/EBP-α to Promote Claudin-5 Expression and Enhance Endothelial Barrier Function.","date":"2020","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/32673519","citation_count":103,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10906322","id":"PMC_10906322","title":"C/EBP regulates hepatic transcription of 11beta -hydroxysteroid dehydrogenase type 1. A novel mechanism for cross-talk between the C/EBP and glucocorticoid signaling pathways.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10906322","citation_count":102,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8758898","id":"PMC_8758898","title":"C/EBP activators are required for HIV-1 replication and proviral induction in monocytic cell lines.","date":"1996","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/8758898","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21389327","id":"PMC_21389327","title":"IMiD immunomodulatory compounds block C/EBP{beta} translation through eIF4E down-regulation resulting in inhibition of MM.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21389327","citation_count":83,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12242300","id":"PMC_12242300","title":"Calreticulin interacts with C/EBPalpha and C/EBPbeta mRNAs and represses translation of C/EBP proteins.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12242300","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11792653","id":"PMC_11792653","title":"C/EBP DNA-binding activity is upregulated by a glucocorticoid-dependent mechanism in septic muscle.","date":"2002","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11792653","citation_count":74,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1459454","id":"PMC_1459454","title":"Drosophila C/EBP: a tissue-specific DNA-binding protein required for embryonic development.","date":"1992","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/1459454","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21666710","id":"PMC_21666710","title":"C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21666710","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18163952","id":"PMC_18163952","title":"The interferon signaling network and transcription factor C/EBP-beta.","date":"2007","source":"Cellular & molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/18163952","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25876105","id":"PMC_25876105","title":"Overexpression of the novel senescence marker β-galactosidase (GLB1) in prostate cancer predicts reduced PSA recurrence.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25876105","citation_count":64,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24351550","id":"PMC_24351550","title":"C/EBP homologous protein drives pro-catabolic responses in chondrocytes.","date":"2013","source":"Arthritis research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/24351550","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10845904","id":"PMC_10845904","title":"Sp1 and C/EBP are necessary to activate the lactoferrin gene promoter during myeloid differentiation.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10845904","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11980905","id":"PMC_11980905","title":"Regulation of CCAAT/enhancer-binding protein (C/EBP) activator proteins by heterodimerization with C/EBPgamma (Ig/EBP).","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11980905","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12692227","id":"PMC_12692227","title":"The Papillomavirus E2 protein binds to and synergizes with C/EBP factors involved in keratinocyte differentiation.","date":"2003","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/12692227","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15368440","id":"PMC_15368440","title":"C/EBP beta isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver.","date":"2004","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/15368440","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8830049","id":"PMC_8830049","title":"Induction of the C/EBP beta gene by dexamethasone and glucagon in primary-cultured rat hepatocytes.","date":"1996","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8830049","citation_count":59,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18832658","id":"PMC_18832658","title":"Human C/EBP-epsilon activator and repressor isoforms differentially reprogram myeloid lineage commitment and differentiation.","date":"2008","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/18832658","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31338984","id":"PMC_31338984","title":"Quercetin-Induced miR-369-3p Suppresses Chronic Inflammatory Response Targeting C/EBP-β.","date":"2019","source":"Molecular nutrition & food research","url":"https://pubmed.ncbi.nlm.nih.gov/31338984","citation_count":57,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8692870","id":"PMC_8692870","title":"A novel function for Myc: inhibition of C/EBP-dependent gene activation.","date":"1996","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8692870","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11038443","id":"PMC_11038443","title":"Novel and recurrent EBP mutations in X-linked dominant chondrodysplasia punctata.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11038443","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20209087","id":"PMC_20209087","title":"C/EBP-beta regulates endoplasmic reticulum stress-triggered cell death in mouse and human models.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20209087","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31534909","id":"PMC_31534909","title":"Human GLB1 knockout cerebral organoids: A model system for testing AAV9-mediated GLB1 gene therapy for reducing GM1 ganglioside storage in GM1 gangliosidosis.","date":"2019","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/31534909","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11750126","id":"PMC_11750126","title":"Molecular cloning, genetic mapping, and expression analysis of four zebrafish c/ebp genes.","date":"2001","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11750126","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11916518","id":"PMC_11916518","title":"C/EBP-beta, C/EBP-delta, PU.1, AML1 genes: mutational analysis in 381 samples of hematopoietic and solid malignancies.","date":"2002","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/11916518","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16667080","id":"PMC_16667080","title":"Molecular characterization of the major maize embryo globulin encoded by the glb1 gene.","date":"1989","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16667080","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8680485","id":"PMC_8680485","title":"Control of adipocyte differentiation by CCAAT/enhancer binding protein alpha (C/EBP alpha).","date":"1996","source":"International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/8680485","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26118414","id":"PMC_26118414","title":"Endogenous prostaglandin E2 potentiates anti-inflammatory phenotype of macrophage through the CREB-C/EBP-β cascade.","date":"2015","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26118414","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12606546","id":"PMC_12606546","title":"Transcription cooperation by NFAT.C/EBP composite enhancer complex.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12606546","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28854265","id":"PMC_28854265","title":"Zinc transporter ZIP13 suppresses beige adipocyte biogenesis and energy expenditure by regulating C/EBP-β expression.","date":"2017","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28854265","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15710476","id":"PMC_15710476","title":"Cooperative interaction of C/EBP beta and Tat modulates MCP-1 gene transcription in astrocytes.","date":"2005","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/15710476","citation_count":46,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15688424","id":"PMC_15688424","title":"Myxoid liposarcoma FUS-DDIT3 fusion oncogene induces C/EBP beta-mediated interleukin 6 expression.","date":"2005","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15688424","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22242125","id":"PMC_22242125","title":"Stress-induced C/EBP homology protein (CHOP) represses MyoD transcription to delay myoblast differentiation.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22242125","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11438745","id":"PMC_11438745","title":"C/EBP epsilon mediates myeloid differentiation and is regulated by the CCAAT displacement protein (CDP/cut).","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11438745","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25766403","id":"PMC_25766403","title":"The role of C/EBP-β LIP in multidrug resistance.","date":"2015","source":"Journal of the National Cancer Institute","url":"https://pubmed.ncbi.nlm.nih.gov/25766403","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22776069","id":"PMC_22776069","title":"Inhibition of CD200R1 expression by C/EBP β in reactive microglial cells.","date":"2012","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/22776069","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16949670","id":"PMC_16949670","title":"Fibrates upregulate TRB3 in lymphocytes independent of PPAR alpha by augmenting CCAAT/enhancer-binding protein beta (C/EBP beta) expression.","date":"2006","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16949670","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8440378","id":"PMC_8440378","title":"Differential adrenergic regulation of C/EBP alpha and C/EBP beta in brown adipose tissue.","date":"1993","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8440378","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32034145","id":"PMC_32034145","title":"C/EBPɑ is crucial determinant of epithelial maintenance by preventing epithelial-to-mesenchymal transition.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32034145","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12855590","id":"PMC_12855590","title":"RUNX/AML and C/EBP factors regulate CD11a integrin expression in myeloid cells through overlapping regulatory elements.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12855590","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24398327","id":"PMC_24398327","title":"miRNA-130a regulates C/EBP-ε expression during granulopoiesis.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/24398327","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12970736","id":"PMC_12970736","title":"Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12970736","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12202226","id":"PMC_12202226","title":"Interaction between TGFbeta signaling proteins and C/EBP controls basal and Tat-mediated transcription of HIV-1 LTR in astrocytes.","date":"2002","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/12202226","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11861297","id":"PMC_11861297","title":"Macrophage functional maturation and cytokine production are impaired in C/EBP epsilon-deficient mice.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11861297","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23881867","id":"PMC_23881867","title":"Reciprocal modulation of C/EBP-α and C/EBP-β by IL-13 in activated microglia prevents neuronal death.","date":"2013","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23881867","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23646198","id":"PMC_23646198","title":"Ablation of C/EBP homologous protein does not protect T17M RHO mice from retinal degeneration.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23646198","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15064728","id":"PMC_15064728","title":"Identification of murine and human XCP1 genes as C/EBP-epsilon-dependent members of FIZZ/Resistin gene family.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15064728","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31909714","id":"PMC_31909714","title":"Roles of C/EBP class bZip proteins in the growth and cell competition of Rp ('Minute') mutants in Drosophila.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31909714","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15519652","id":"PMC_15519652","title":"Suppression of C/EBP alpha expression in biliary cell differentiation from hepatoblasts during mouse liver development.","date":"2004","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/15519652","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36396643","id":"PMC_36396643","title":"A Glb1-2A-mCherry reporter monitors systemic aging and predicts lifespan in middle-aged mice.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36396643","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18166146","id":"PMC_18166146","title":"C/EBP homologous protein is crucial for the acceleration of experimental pancreatitis.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/18166146","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16220546","id":"PMC_16220546","title":"C/EBP homologous protein is necessary for normal osteoblastic function.","date":"2006","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16220546","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26372225","id":"PMC_26372225","title":"XBP1-Independent UPR Pathways Suppress C/EBP-β Mediated Chondrocyte Differentiation in ER-Stress Related Skeletal Disease.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26372225","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8314590","id":"PMC_8314590","title":"The human C/EBP delta (CRP3/CELF) gene: structure and chromosomal localization.","date":"1993","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8314590","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29748013","id":"PMC_29748013","title":"Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma.","date":"2018","source":"Lung cancer (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/29748013","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20829351","id":"PMC_20829351","title":"C/EBP{delta} and STAT-1 are required for TLR8 transcriptional activity.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20829351","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25314137","id":"PMC_25314137","title":"Mmu-miR-615-3p regulates lipoapoptosis by inhibiting C/EBP homologous protein.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25314137","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29425932","id":"PMC_29425932","title":"Ablation of C/EBP homologous protein attenuates renal fibrosis after ureteral obstruction by reducing autophagy and microtubule disruption.","date":"2018","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/29425932","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20175788","id":"PMC_20175788","title":"Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations.","date":"2010","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20175788","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22178079","id":"PMC_22178079","title":"Molecular responses of choroidal endothelial cells to elastin derived peptides through the elastin-binding protein (GLB1).","date":"2011","source":"Matrix biology : journal of the International Society for Matrix Biology","url":"https://pubmed.ncbi.nlm.nih.gov/22178079","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27927209","id":"PMC_27927209","title":"Coordinated inhibition of C/EBP by Tribbles in multiple tissues is essential for Caenorhabditis elegans development.","date":"2016","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/27927209","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22396222","id":"PMC_22396222","title":"Artemisinic acid is a regulator of adipocyte differentiation and C/EBP δ expression.","date":"2012","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22396222","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21308746","id":"PMC_21308746","title":"Role of C/EBP-β, p38 MAPK, and MKK6 in IL-1β-mediated C3 gene regulation in astrocytes.","date":"2011","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21308746","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29884649","id":"PMC_29884649","title":"Impaired DNA demethylation of C/EBP sites causes premature aging.","date":"2018","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/29884649","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21600648","id":"PMC_21600648","title":"C/EBP-α and C/EBP-β-mediated adipogenesis of human mesenchymal stem cells (hMSCs) using PLGA nanoparticles complexed with poly(ethyleneimmine).","date":"2011","source":"Biomaterials","url":"https://pubmed.ncbi.nlm.nih.gov/21600648","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24850428","id":"PMC_24850428","title":"C/EBP homologous protein inhibits tissue repair in response to gut injury and is inversely regulated with chronic inflammation.","date":"2014","source":"Mucosal immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24850428","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12760743","id":"PMC_12760743","title":"Cloning of an emopamil-binding protein (EBP)-like protein that lacks sterol delta8-delta7 isomerase activity.","date":"2003","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12760743","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19222842","id":"PMC_19222842","title":"Cyclic regulation of transcription factor C/EBP beta in human endometrium.","date":"2009","source":"Reproductive biology and endocrinology : RB&E","url":"https://pubmed.ncbi.nlm.nih.gov/19222842","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18406180","id":"PMC_18406180","title":"Sumoylation and the function of CCAAT enhancer binding protein alpha (C/EBP alpha).","date":"2008","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/18406180","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23305818","id":"PMC_23305818","title":"The kinase domain of Drosophila Tribbles is required for turnover of fly C/EBP during cell migration.","date":"2013","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23305818","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11012671","id":"PMC_11012671","title":"Regulation of Gadd45gamma expression by C/EBP.","date":"2000","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11012671","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20386538","id":"PMC_20386538","title":"C/EBP alpha expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis.","date":"2010","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/20386538","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27644413","id":"PMC_27644413","title":"Role of C/EBP-α in Adriamycin-induced podocyte injury.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27644413","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16626397","id":"PMC_16626397","title":"Senescence-associated beta-galactosidase is lysosomal beta-galactosidase.","date":"2006","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/16626397","citation_count":1124,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11927518","id":"PMC_11927518","title":"Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction.","date":"2002","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/11927518","citation_count":879,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"5647842","id":"PMC_5647842","title":"Generalized gangliosidosis: beta-galactosidase deficiency.","date":"1968","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/5647842","citation_count":421,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8670798","id":"PMC_8670798","title":"The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8670798","citation_count":357,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23042114","id":"PMC_23042114","title":"Genome-wide association study identifies eight new susceptibility loci for atopic dermatitis in the Japanese population.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23042114","citation_count":278,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21900206","id":"PMC_21900206","title":"A directed protein interaction network for investigating intracellular signal transduction.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21900206","citation_count":258,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27173435","id":"PMC_27173435","title":"An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27173435","citation_count":211,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21988832","id":"PMC_21988832","title":"Toward an understanding of the protein interaction network of the human liver.","date":"2011","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/21988832","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18524657","id":"PMC_18524657","title":"GM1 gangliosidosis: review of clinical, molecular, and therapeutic aspects.","date":"2008","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18524657","citation_count":194,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25544563","id":"PMC_25544563","title":"Global mapping of herpesvirus-host protein complexes reveals a transcription strategy for late genes.","date":"2014","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/25544563","citation_count":173,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33939265","id":"PMC_33939265","title":"Senescence-associated β-galactosidase reveals the abundance of senescent CD8+ T cells in aging humans.","date":"2021","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/33939265","citation_count":164,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8383699","id":"PMC_8383699","title":"The 67-kD elastin/laminin-binding protein is related to an enzymatically inactive, alternatively spliced form of beta-galactosidase.","date":"1993","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/8383699","citation_count":157,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9497360","id":"PMC_9497360","title":"The 67-kDa enzymatically inactive alternatively spliced variant of beta-galactosidase is identical to the elastin/laminin-binding protein.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9497360","citation_count":154,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23533145","id":"PMC_23533145","title":"In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.","date":"2013","source":"Proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23533145","citation_count":138,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"3922758","id":"PMC_3922758","title":"Human placental neuraminidase. Activation, stabilization and association with beta-galactosidase and its protective protein.","date":"1985","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3922758","citation_count":134,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16314420","id":"PMC_16314420","title":"Lysosomal sialidase (neuraminidase-1) is targeted to the cell surface in a multiprotein complex that facilitates elastic fiber assembly.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16314420","citation_count":130,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23376485","id":"PMC_23376485","title":"Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.","date":"2013","source":"Journal of proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/23376485","citation_count":126,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49501,"output_tokens":1725,"usd":0.087189},"stage2":{"model":"claude-opus-4-6","input_tokens":4771,"output_tokens":1706,"usd":0.099757},"total_usd":0.463369,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":61662,"output_tokens":4054,"usd":0.122898},"round2_rules_fired":"R2,R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6830,"output_tokens":2728,"usd":0.153525}},"stage1_raw":"Looking at the abstracts, I need to identify which ones are about GLB1 (lysosomal β-galactosidase) versus the many papers about C/EBP transcription factors (which dominate this corpus but are clearly not GLB1). The GLB1 gene encodes lysosomal acid β-galactosidase, responsible for GM1 gangliosidosis and Morquio B disease. I also note that GLB1 has an alternatively spliced form that acts as elastin-binding protein (EBP).\n\nRelevant GLB1 papers: #38, #50, #77, #86, #87.\n\nPaper #53 is about maize Glb1 (a seed storage protein) - this is a symbol collision, skip.\nPaper #48 is about EBP (emopamil-binding protein), not GLB1.\nPaper #94 is about EBPL (EBP-like protein), not GLB1.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2011,\n      \"finding\": \"An alternatively spliced form of GLB1 (lysosomal β-galactosidase) is expressed on the surface of human choroidal endothelial cells and functions as a receptor for elastin-derived peptides (EDPs), mediating EDP-induced cell migration and neovascular phenotypes. Inhibition of GLB1 (but not other EDP-binding proteins) blocked EDP-stimulated choroidal endothelial cell migration, establishing GLB1 as the functional EDP receptor in this context.\",\n      \"method\": \"Reverse transcription PCR for GLB1 expression; migration assay with receptor-specific inhibitors; in vivo mouse EDP injection with microarray and TEM analysis\",\n      \"journal\": \"Matrix biology : journal of the International Society for Matrix Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct functional receptor identification by inhibitor-based migration assay with in vivo follow-up, single lab\",\n      \"pmids\": [\"22178079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GLB1 (lysosomal β-galactosidase) protein accumulates during both replicative senescence and therapy-induced senescence in prostate epithelial cells, correlating with senescent morphology and p16 (CDKN2A) expression. GLB1 is established as the molecular origin of senescence-associated β-galactosidase (SA-β-gal) activity detected at pH 6.\",\n      \"method\": \"In vitro replicative senescence of primary prostate epithelial cells; therapy-induced senescence in PCa lines; immunofluorescent staining with quantitative imaging (AQUA/Vectra); correlation with Ki67 and HP1γ\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — direct in vitro characterization linking GLB1 protein accumulation to senescent phenotype, single lab with multiple orthogonal markers\",\n      \"pmids\": [\"25876105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CRISPR/Cas9 knockout of GLB1 in human iPSC-derived cerebral organoids causes progressive accumulation of GM1 ganglioside, directly demonstrating that GLB1 encodes the lysosomal β-galactosidase responsible for GM1 ganglioside catabolism in human CNS cells. AAV9-mediated GLB1 gene delivery to knockout organoids significantly increased β-galactosidase activity and reduced GM1 ganglioside storage.\",\n      \"method\": \"CRISPR/Cas9 genome editing of GLB1 exons 2 and 6 in human iPSCs; cerebral organoid generation; β-gal enzyme activity assay; lipid quantification; AAV9-GLB1 rescue experiment\",\n      \"journal\": \"Molecular genetics and metabolism reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstitution via gene delivery rescue combined with enzymatic activity assay and substrate accumulation measurement in a human model system\",\n      \"pmids\": [\"31534909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Missense and truncating mutations in GLB1 cause GM1 gangliosidosis with variable severity; specific GLB1 alleles were shown by overexpression in COS-1 cells and fibroblast subcellular localization studies to produce dysfunctional β-galactosidase protein with altered trafficking, allowing genotype-phenotype correlations to be established for 10 alleles.\",\n      \"method\": \"Overexpression of mutant GLB1 alleles in COS-1 cells; subcellular localization of mutant proteins in patient fibroblasts; β-galactosidase enzyme activity assay\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional overexpression and localization studies directly linking specific mutations to loss of enzymatic activity and mistrafficking, single lab\",\n      \"pmids\": [\"20175788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A Glb1-2A-mCherry (GAC) knock-in reporter allele in mice demonstrates that GLB1/lysosomal β-galactosidase expression increases linearly with chronological age in tissues, is elevated in pathological senescence (bleomycin-induced lung injury), and is reduced by senolytic treatment (dasatinib + quercetin), establishing GLB1 enzymatic upregulation as a functional marker of in vivo cellular senescence.\",\n      \"method\": \"CRISPR knock-in reporter mouse generation; fluorescence imaging; lifespan cohort analysis; bleomycin-induced senescence model; senolytic drug treatment with GAC signal quantification\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo genetic reporter directly linked to GLB1 locus with functional validation across multiple biological contexts and pharmacological intervention\",\n      \"pmids\": [\"36396643\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GLB1 encodes lysosomal acid β-galactosidase, which hydrolyzes β-galactose from GM1 ganglioside and other glycoconjugates in lysosomes; loss-of-function mutations cause progressive GM1 ganglioside accumulation leading to GM1 gangliosidosis, while an alternatively spliced surface isoform acts as an elastin-derived peptide receptor on endothelial cells, and GLB1 enzymatic activity is upregulated during cellular senescence where it is the molecular basis of senescence-associated β-galactosidase activity.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper first, then extract discoveries only from KEEP papers.\n\n**Classification:**\n\nPapers 1-100 from retrieved corpus: The vast majority (papers 1-47, 49, 51-100 in the retrieved set) are about C/EBP transcription factors, EBP (emopamil-binding protein), or maize Glb1 seed storage protein — none of these are the human GLB1 (lysosomal β-galactosidase) gene. \n\n**KEEP from retrieved corpus:**\n- Paper [38]: GLB1 as senescence marker in prostate cancer — KEEP\n- Paper [50]: GLB1 knockout cerebral organoids, AAV9 gene therapy — KEEP\n- Paper [87]: GLB1 alternatively spliced form as elastin receptor on choroidal endothelial cells — KEEP\n- Paper [53]: maize Glb1 globulin — EXCLUDE (symbol collision, plant seed storage protein)\n- Paper [48]: EBP mutations in chondrodysplasia — EXCLUDE (different gene, EBP = emopamil-binding protein)\n- Paper [94]: EBPL cloning — EXCLUDE (different gene)\n- Paper [75]: Drosophila C/EBP bZIP — EXCLUDE (C/EBP, not GLB1)\n\n**KEEP from gene2pubmed curated papers:**\n- [2]: SA-β-gal is lysosomal β-galactosidase (GLB1) — KEEP\n- [6]: SA-β-gal in endothelial cells/atherosclerosis — KEEP (uses SA-β-gal, but no mechanistic finding about GLB1 itself)\n- [15]: β-galactosidase deficiency in gangliosidosis — KEEP\n- [22]: GM1 gangliosidosis review — KEEP\n- [24]: SA-β-gal in CD8+ T cells — KEEP (uses SA-β-gal assay)\n- [25]: 67-kDa elastin/laminin-binding protein related to alternatively spliced β-galactosidase — KEEP\n- [26]: 67-kDa splice variant of β-galactosidase = EBP — KEEP\n- [28]: Neuraminidase associated with β-galactosidase and protective protein — KEEP\n- [29]: EBP (spliced β-gal variant) forms complex with neuraminidase-1 — KEEP\n- [77]: Glb1-2A-mCherry reporter monitors aging — KEEP\n- [86]: GLB1 mutations in GM1 gangliosidosis — KEEP\n- [3],[4],[5],[7],[8],[9]: Large-scale interactome studies mentioning GLB1 — these are generic proteomics, no specific mechanistic findings about GLB1\n- [1],[13]: MGC cDNA — no mechanistic finding\n- [10]: GO annotation propagation — no mechanistic finding\n- [11],[27],[30]: Proteomics/exosome studies — no specific GLB1 mechanism\n- [12]: Oligo-capping method — no mechanistic finding\n- [14]: OpenCell — localization data\n- [16]: Alternative promoters — no specific GLB1 mechanism\n- [17]: Chaperone refolding using β-galactosidase as substrate — EXCLUDE (β-galactosidase used as generic substrate, not about GLB1 function)\n- [18]: GWAS for atopic dermatitis — EXCLUDE (association study)\n- [19],[21],[23]: Interaction network studies — no specific GLB1 mechanism\n- [20]: Ciliary organelle landscape — no specific GLB1 mechanism\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1968,\n      \"finding\": \"Profound deficiency of β-galactosidase activity (failing to cleave both p-nitrophenyl-β-D-galactopyranoside and GM1 ganglioside labeled with C14) was identified in tissues of patients with generalized gangliosidosis, establishing that defective lysosomal β-galactosidase (GLB1) is the fundamental enzymatic defect responsible for GM1 ganglioside accumulation in this disease.\",\n      \"method\": \"Enzymatic activity assay on liver, spleen, kidney and brain tissue homogenates from patients\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro enzymatic assay with defined substrate, foundational paper replicated extensively\",\n      \"pmids\": [\"5647842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1985,\n      \"finding\": \"Lysosomal β-galactosidase exists as a high-density multimeric complex that associates with both a 32-kDa protective protein (CTSA/cathepsin A) and neuraminidase, and formation of this multiprotein complex is required for neuraminidase catalytic activity; absence of the protective protein in galactosialidosis explains the secondary neuraminidase deficiency in that disorder.\",\n      \"method\": \"β-galactosidase affinity chromatography, immunotitration with monospecific antibodies, sucrose density gradient centrifugation of human placental fractions\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical reconstitution and affinity chromatography with multiple orthogonal methods; foundational for understanding the lysosomal multienzyme complex\",\n      \"pmids\": [\"3922758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"An alternatively spliced, enzymatically inactive 67-kDa form of β-galactosidase (encoded by GLB1) was identified as immunologically and functionally similar to the 67-kDa cell-surface elastin/laminin-binding protein (EBP); a unique peptide (S-GAL) derived from the frameshift-generated sequence of this splice variant binds elastin and laminin but not fibronectin or collagens.\",\n      \"method\": \"Antibody raised to unique splice-variant peptide; Western blot; elastin and laminin affinity column binding assays; immunohistochemistry of aortic tissue\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (affinity binding, immunology, peptide competition) in a single study; replicated in subsequent work\",\n      \"pmids\": [\"8383699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The 67-kDa alternatively spliced variant of GLB1 (S-gal) was conclusively identified as the elastin/laminin-binding protein: full-length S-gal cDNA expressed in COS-1 cells and EBP-deficient smooth muscle cells produced a 67-kDa protein that localized to the cell surface, bound elastin, increased cell adhesion to elastin, and corrected impaired elastic fiber assembly in deficient cells.\",\n      \"method\": \"cDNA transfection, in vitro transcription/translation, elastin/laminin affinity chromatography, immunolocalization, cell adhesion assay, elastic fiber assembly assay in EBP-deficient smooth muscle cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in multiple cell types with functional rescue; definitive identification of splice variant function\",\n      \"pmids\": [\"9497360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The alternatively spliced 67-kDa EBP (GLB1 splice variant) forms a cell surface-targeted multiprotein complex with protective protein/cathepsin A and sialidase (neuraminidase-1); this complex facilitates elastic fiber assembly by enabling neuraminidase-1 to remove terminal sialic acids from microfibrillar glycoproteins, exposing galactosugars that interact with the galectin domain of EBP and trigger tropoelastin release and assembly.\",\n      \"method\": \"Co-immunoprecipitation, sialidase inhibitor treatment, neuraminidase-1 cDNA transduction of sialidosis/galactosialidosis patient fibroblasts, chick embryo elastogenesis assay, bacterial sialidase rescue experiment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including genetic rescue in patient-derived cells and functional reconstitution\",\n      \"pmids\": [\"16314420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Senescence-associated β-galactosidase (SA-β-gal) activity detectable at pH 6.0 in senescent cells originates from GLB1, the gene encoding lysosomal β-D-galactosidase: fibroblasts from GM1-gangliosidosis patients (defective lysosomal β-galactosidase) and normal late-passage fibroblasts depleted of GLB1 mRNA by shRNA both failed to express SA-β-gal despite undergoing replicative senescence; SA-β-gal induction during senescence was due at least in part to increased GLB1 protein expression.\",\n      \"method\": \"shRNA knockdown of GLB1, SA-β-gal activity assay at pH 6.0, patient fibroblasts from GM1-gangliosidosis, HPV E7 repression-induced senescence model, Western blot\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — loss-of-function (shRNA and genetic disease cells) with specific phenotypic readout across multiple model systems; widely replicated\",\n      \"pmids\": [\"16626397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Genotype-phenotype analysis of 28 GLB1 mutations in GM1 gangliosidosis patients revealed that overexpression of missense mutations in COS-1 cells and assessment of subcellular localization of mutant proteins in fibroblasts can predict phenotype specificity; mutations producing truncated proteins consistently result in typical CDPX2-like severe phenotype, while missense mutations show variable phenotypic outcomes, indicating that residual β-galactosidase enzyme activity correlates with clinical severity.\",\n      \"method\": \"Overexpression in COS-1 cells, immunofluorescence subcellular localization in patient fibroblasts, DNA sequencing, β-galactosidase enzyme activity assay\",\n      \"journal\": \"Clinical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — cell-based expression with functional readout; single study but covers multiple alleles with defined phenotypic correlation\",\n      \"pmids\": [\"20175788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"An alternatively spliced form of GLB1 (the EBP splice variant) is present on human choroidal endothelial cells and acts as a cell-surface receptor for elastin-derived peptides (EDPs), mediating their pro-angiogenic effects; EDP-induced cell migration was blocked by inhibitors targeting EBP/GLB1 but not other EDP-binding proteins, and elevated circulating EDPs in vivo increased collagen IV expression and deposition in the RPE/choroid.\",\n      \"method\": \"RT-PCR for GLB1 isoform expression, cell migration assay with receptor-specific inhibitors, in vivo mouse EDP injection with electroretinography, transmission electron microscopy, and microarray analysis\",\n      \"journal\": \"Matrix biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — receptor identification by pharmacological inhibition and expression analysis, supported by in vivo functional data\",\n      \"pmids\": [\"22178079\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"GLB1 protein (lysosomal β-galactosidase) accumulates in replicative senescence and therapy-induced senescence in prostate epithelial cells and cancer lines, correlating with senescent morphology and p16/CDKN2A expression; in tissue microarrays, GLB1 expression is elevated in high-grade prostatic intraepithelial neoplasia and primary cancer compared with benign tissue, with senescent cells showing low Ki67 and elevated HP1γ.\",\n      \"method\": \"Immunofluorescent staining with new GLB1 antibody, automated quantitative imaging (AQUA and Vectra), replicative senescence passage assay in primary cultures, chemotherapy-induced senescence in PCa lines\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct protein localization and expression correlation with senescence markers; functional link to senescence biology established but mechanistic depth limited\",\n      \"pmids\": [\"25876105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CRISPR/Cas9 knockout of GLB1 in human iPSC-derived cerebral organoids caused progressive accumulation of GM1 ganglioside; microinjection of AAV9-GLB1 vector into these organoids significantly increased β-galactosidase activity and reduced GM1 ganglioside content, demonstrating that GLB1 gene delivery is sufficient to restore enzymatic function and reduce substrate storage in a human CNS model.\",\n      \"method\": \"CRISPR/Cas9 genome editing targeting GLB1 exons 2 and 6, cerebral organoid generation, β-galactosidase enzyme activity assay, GM1 ganglioside quantification, AAV9-GLB1 microinjection\",\n      \"journal\": \"Molecular genetics and metabolism reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genetic knockout with substrate accumulation phenotype and genetic rescue by AAV9-GLB1 in a human CNS organoid model; proof-of-concept with rigorous controls\",\n      \"pmids\": [\"31534909\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"A Glb1-2A-mCherry (GAC) knock-in reporter allele at the endogenous Glb1 locus in mice showed that GLB1/lysosomal β-galactosidase protein levels increase linearly with chronological age in middle-aged mice and are exponentially elevated in bleomycin-induced pathological senescence in the lung; treatment with senolytics dasatinib and quercetin reduced GAC signal in bleomycin-treated mice, confirming that GLB1 expression marks senescent cell burden in vivo.\",\n      \"method\": \"CRISPR knock-in reporter allele (Glb1-2A-mCherry), cohort aging study, bleomycin lung injury model, in vivo imaging, senolytic drug treatment\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — endogenous reporter knock-in with genetic and pharmacological validation across multiple experimental conditions\",\n      \"pmids\": [\"36396643\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GLB1 encodes lysosomal β-D-galactosidase, whose deficiency causes GM1 gangliosidosis through accumulation of GM1 ganglioside; an alternatively spliced, enzymatically inactive 67-kDa isoform functions as the cell-surface elastin/laminin-binding protein (EBP) that, in a multiprotein complex with cathepsin A/protective protein and neuraminidase-1, acts as a recyclable chaperone facilitating tropoelastin secretion and elastic fiber assembly; the canonical lysosomal form is upregulated during cellular senescence and is the molecular origin of senescence-associated β-galactosidase (SA-β-gal) activity.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GLB1 encodes lysosomal acid β-galactosidase, which cleaves terminal β-galactose residues from GM1 ganglioside and other glycoconjugates within lysosomes; CRISPR knockout in human iPSC-derived cerebral organoids causes progressive GM1 ganglioside accumulation that is rescued by AAV9-mediated GLB1 gene delivery [PMID:31534909]. Loss-of-function mutations in GLB1 cause GM1 gangliosidosis, with specific missense and truncating alleles producing dysfunctional enzyme with altered lysosomal trafficking [PMID:20175788]. GLB1 protein accumulates during replicative and therapy-induced cellular senescence and constitutes the molecular basis of senescence-associated β-galactosidase (SA-β-gal) activity; a Glb1 knock-in reporter in mice confirmed that GLB1 expression increases with chronological age and is reduced by senolytic treatment [PMID:25876105, PMID:36396643]. An alternatively spliced GLB1 isoform is expressed on the surface of choroidal endothelial cells and functions as a receptor for elastin-derived peptides, mediating EDP-induced cell migration [PMID:22178079].\",\n  \"teleology\": [\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing how specific GLB1 mutations impair enzyme function answered the question of how allelic variation drives GM1 gangliosidosis severity, revealing that missense and truncating mutations produce misfolded or mistrafficked β-galactosidase with reduced or absent activity.\",\n      \"evidence\": \"Overexpression of 10 mutant GLB1 alleles in COS-1 cells and subcellular localization in patient fibroblasts\",\n      \"pmids\": [\"20175788\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab study without independent replication of all genotype-phenotype correlations\",\n        \"Structural basis for misfolding of individual alleles not determined\",\n        \"No in vivo confirmation of trafficking defects\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identifying an alternatively spliced GLB1 isoform as the functional elastin-derived peptide receptor on endothelial cells revealed a non-lysosomal, cell-surface signaling role for a GLB1 gene product.\",\n      \"evidence\": \"RT-PCR, migration assays with receptor-specific inhibitors, and in vivo EDP injection in mouse choroidal endothelial cells\",\n      \"pmids\": [\"22178079\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single-lab finding; receptor identity not confirmed by independent groups or orthogonal binding assays\",\n        \"Downstream signaling pathway from surface GLB1 isoform not delineated\",\n        \"Structural basis distinguishing the surface isoform from the lysosomal enzyme not resolved\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating that GLB1 protein accumulates during cellular senescence identified the molecular origin of SA-β-gal activity, resolving a long-standing question about what enzyme underlies this widely used senescence marker.\",\n      \"evidence\": \"Replicative and therapy-induced senescence in prostate epithelial cells with quantitative immunofluorescence correlated to p16 and Ki67\",\n      \"pmids\": [\"25876105\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism driving GLB1 upregulation during senescence not identified\",\n        \"Single-lab correlative study; causal link between GLB1 accumulation and senescent phenotype not established\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"CRISPR knockout and AAV9-mediated rescue in human cerebral organoids reconstituted the complete loss-and-gain cycle of GLB1 enzymatic function, definitively establishing GLB1 as the enzyme responsible for GM1 ganglioside catabolism in human CNS tissue.\",\n      \"evidence\": \"CRISPR/Cas9 knockout of GLB1 in human iPSC-derived cerebral organoids with enzyme activity assays, lipid quantification, and AAV9-GLB1 gene delivery rescue\",\n      \"pmids\": [\"31534909\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Long-term neuronal functional consequences of GLB1 loss not assessed in organoids\",\n        \"No evaluation of secondary storage materials beyond GM1 ganglioside\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"A genetic knock-in reporter directly at the Glb1 locus validated GLB1 upregulation as a bona fide in vivo senescence marker across aging and pathological contexts, and demonstrated its reversibility by senolytic drugs.\",\n      \"evidence\": \"CRISPR Glb1-2A-mCherry knock-in mouse with lifespan cohort, bleomycin lung injury model, and dasatinib+quercetin senolytic treatment\",\n      \"pmids\": [\"36396643\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Transcriptional or post-transcriptional mechanism driving age-dependent GLB1 upregulation remains unknown\",\n        \"Whether GLB1 enzymatic activity itself contributes to senescence biology or is merely a bystander marker is unresolved\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The transcriptional and post-translational mechanisms that upregulate GLB1 during senescence, and whether elevated GLB1 activity has a functional role in the senescent phenotype beyond serving as a biomarker, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No causal evidence that GLB1 enzymatic activity drives any aspect of senescence\",\n        \"Structural basis for substrate specificity and allosteric regulation of GLB1 not fully resolved\",\n        \"Physiological relevance of the surface EDP-receptor isoform in vivo not independently confirmed\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"GLB1 encodes lysosomal β-D-galactosidase, an acid hydrolase that cleaves terminal β-galactosyl residues from glycosphingolipids, glycoproteins, and keratan sulfate, and whose deficiency causes the lysosomal storage disorder GM1 gangliosidosis through accumulation of GM1 ganglioside [PMID:5647842, PMID:31534909]. Within the lysosome, GLB1 functions as part of a multienzyme complex with protective protein/cathepsin A (CTSA) and neuraminidase-1 (NEU1), and this association is required for neuraminidase catalytic activity [PMID:3922758, PMID:16314420]. An alternatively spliced, enzymatically inactive 67-kDa isoform serves as the elastin/laminin-binding protein (EBP) on the cell surface, where it chaperones tropoelastin secretion and elastic fiber assembly by coordinating with CTSA and NEU1 to release tropoelastin upon exposure of galactosugars on microfibrils [PMID:8383699, PMID:9497360, PMID:16314420]. The canonical lysosomal enzyme is also the molecular source of senescence-associated β-galactosidase (SA-β-gal) activity: GLB1 protein is upregulated during replicative and therapy-induced senescence, and its expression increases with chronological age in vivo [PMID:16626397, PMID:36396643].\",\n  \"teleology\": [\n    {\n      \"year\": 1968,\n      \"claim\": \"Establishing the primary enzymatic defect: demonstrating that profound loss of β-galactosidase activity is the biochemical basis of generalized (GM1) gangliosidosis resolved the question of which enzyme is responsible for GM1 ganglioside catabolism.\",\n      \"evidence\": \"Enzymatic activity assay on patient tissue homogenates using synthetic and radiolabeled GM1 substrates\",\n      \"pmids\": [\"5647842\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No molecular cloning or gene identification at this stage\", \"Genotype–phenotype spectrum not yet explored\"]\n    },\n    {\n      \"year\": 1985,\n      \"claim\": \"Identifying the lysosomal multienzyme complex: showing that β-galactosidase, protective protein/cathepsin A, and neuraminidase form a high-molecular-weight complex — and that the protective protein is essential for neuraminidase activity — explained the secondary neuraminidase deficiency in galactosialidosis and established GLB1 as a structural component of this complex.\",\n      \"evidence\": \"Affinity chromatography, immunotitration, and sucrose gradient centrifugation of human placental lysosomes\",\n      \"pmids\": [\"3922758\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and atomic structure of the complex unresolved\", \"Mechanism by which protective protein activates neuraminidase not defined\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Discovering the EBP splice variant: identifying an alternatively spliced, enzymatically inactive 67-kDa GLB1 product as the elastin/laminin-binding protein revealed a bifunctional gene with roles in both lysosomal catabolism and extracellular matrix biology.\",\n      \"evidence\": \"Antibody against the unique splice-variant peptide (S-GAL), Western blot, elastin/laminin affinity chromatography\",\n      \"pmids\": [\"8383699\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether EBP functions independently or requires cofactors for elastic fiber assembly was unknown\", \"In vivo relevance of EBP not yet tested\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Functional reconstitution of EBP: expressing full-length S-gal cDNA in EBP-deficient smooth muscle cells restored cell-surface elastin binding, adhesion, and elastic fiber assembly, definitively proving the splice variant is the functional EBP.\",\n      \"evidence\": \"cDNA transfection into COS-1 and EBP-deficient vascular smooth muscle cells with functional rescue assays\",\n      \"pmids\": [\"9497360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism triggering tropoelastin release from EBP not resolved\", \"Role of associated proteins in elastic fiber assembly not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Elucidating the EBP-mediated elastic fiber assembly mechanism: showing that the EBP/CTSA/NEU1 cell-surface complex uses neuraminidase-1 to desialylate microfibrillar glycoproteins, exposing galactosugars that trigger tropoelastin release, provided a unified mechanism linking the lysosomal multienzyme complex components to extracellular elastogenesis.\",\n      \"evidence\": \"Co-immunoprecipitation, sialidase inhibitors, neuraminidase-1 reconstitution in patient fibroblasts, chick embryo elastogenesis assays\",\n      \"pmids\": [\"16314420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of EBP galectin-domain recognition of galactosugars unresolved\", \"Recycling dynamics of EBP at the cell surface not quantified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying the molecular origin of SA-β-gal: demonstrating that senescence-associated β-galactosidase activity derives from GLB1 — via GLB1 shRNA knockdown and GM1-gangliosidosis patient cells — resolved the long-standing question of the enzyme's identity and showed that GLB1 protein is upregulated during senescence.\",\n      \"evidence\": \"shRNA knockdown of GLB1, SA-β-gal assay at pH 6.0, GM1-gangliosidosis patient fibroblasts, Western blot\",\n      \"pmids\": [\"16626397\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism driving GLB1 transcriptional or translational upregulation in senescence not identified\", \"Functional significance of elevated β-galactosidase in senescent cells (beyond biomarker) unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Mapping genotype–phenotype correlations: systematic analysis of 28 GLB1 mutations showed that residual enzyme activity and subcellular localization of mutant proteins predict clinical severity, advancing understanding of how specific mutations translate to disease spectrum in GM1 gangliosidosis.\",\n      \"evidence\": \"Overexpression of mutant alleles in COS-1 cells, immunofluorescence localization in patient fibroblasts, enzyme activity assays\",\n      \"pmids\": [\"20175788\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vivo validation of genotype–phenotype predictions\", \"Structural basis for misfolding of specific mutants not determined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Proving gene therapy feasibility in a human CNS model: CRISPR knockout of GLB1 in iPSC-derived cerebral organoids recapitulated GM1 ganglioside accumulation, and AAV9-GLB1 delivery rescued enzymatic activity and reduced storage, providing preclinical evidence for gene replacement therapy.\",\n      \"evidence\": \"CRISPR/Cas9 knockout in cerebral organoids, AAV9-GLB1 microinjection, enzyme and ganglioside quantification\",\n      \"pmids\": [\"31534909\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term durability of gene therapy correction not assessed\", \"Cross-correction efficiency in complex brain tissue architecture not evaluated\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Validating GLB1 as an in vivo senescence biomarker: an endogenous Glb1-2A-mCherry knock-in reporter demonstrated that GLB1 expression increases linearly with age and exponentially in pathological senescence, and that senolytic treatment reduces this signal, establishing GLB1 as a quantitative marker of senescent cell burden in living animals.\",\n      \"evidence\": \"CRISPR knock-in reporter mouse, aging cohort, bleomycin lung injury model, dasatinib+quercetin senolytic treatment, in vivo imaging\",\n      \"pmids\": [\"36396643\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GLB1 upregulation is a causal contributor to senescence phenotypes or purely a consequence remains unanswered\", \"Mechanism of transcriptional/translational control of GLB1 during aging still unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The transcriptional and translational regulatory mechanisms that drive GLB1 upregulation during senescence and aging remain undefined, and whether elevated β-galactosidase activity plays a functional role in the senescent phenotype (beyond serving as a biomarker) is an open question.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural model of the full lysosomal multienzyme complex\", \"Whether EBP splice-variant dysregulation contributes to age-related vascular pathology not tested\", \"Functional consequence of elevated lysosomal β-galactosidase in senescent cells unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 1, 9]},\n      {\"term_id\": \"GO:0098631\", \"supporting_discovery_ids\": [2, 3, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [0, 1, 5, 9]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 3, 4, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 9]},\n      {\"term_id\": \"R-HSA-1474244\", \"supporting_discovery_ids\": [3, 4]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 6, 9]}\n    ],\n    \"complexes\": [\n      \"Lysosomal multienzyme complex (GLB1–CTSA–NEU1)\",\n      \"EBP cell-surface complex (67-kDa GLB1 splice variant–CTSA–NEU1)\"\n    ],\n    \"partners\": [\n      \"CTSA\",\n      \"NEU1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}